84 related articles for article (PubMed ID: 14501975)
1. Nuclear factor-kappaB: is it a therapeutic target for the adjuvant treatment of sepsis?
Fink MP
Crit Care Med; 2003 Sep; 31(9):2400-2. PubMed ID: 14501975
[No Abstract] [Full Text] [Related]
2. Sesquiterpene lactone parthenolide ameliorates bladder inflammation and bladder overactivity in cyclophosphamide induced rat cystitis model by inhibiting nuclear factor-kappaB phosphorylation.
Kiuchi H; Takao T; Yamamoto K; Nakayama J; Miyagawa Y; Tsujimura A; Nonomura N; Okuyama A
J Urol; 2009 May; 181(5):2339-48. PubMed ID: 19303104
[TBL] [Abstract][Full Text] [Related]
3. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
[TBL] [Abstract][Full Text] [Related]
4. From mice to men: systematic reviews of animal data could make sepsis trials safer and more productive.
Pitts LR; Simpson SQ
Crit Care Med; 2010 Dec; 38(12):2420-2. PubMed ID: 21088514
[No Abstract] [Full Text] [Related]
5. Parthenolide has limited effects on nuclear factor-kappa beta increases and worsens survival in lipopolysaccharide-challenged C57BL/6J mice.
Li X; Cui X; Li Y; Fitz Y; Hsu L; Eichacker PQ
Cytokine; 2006 Mar; 33(6):299-308. PubMed ID: 16720096
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
[TBL] [Abstract][Full Text] [Related]
7. Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells.
Kishida Y; Yoshikawa H; Myoui A
Clin Cancer Res; 2007 Jan; 13(1):59-67. PubMed ID: 17200339
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin reduces endotoxin-induced nuclear factor kappaB activation and mortality in guinea pigs despite lowering circulating low-density lipoprotein cholesterol.
Fraunberger P; Gröne E; Gröne HJ; Walli AK
Shock; 2009 Aug; 32(2):159-63. PubMed ID: 19008785
[TBL] [Abstract][Full Text] [Related]
9. The green tea polyphenol epigallocatechin-3-gallate improves systemic hemodynamics and survival in rodent models of polymicrobial sepsis.
Wheeler DS; Lahni PM; Hake PW; Denenberg AG; Wong HR; Snead C; Catravas JD; Zingarelli B
Shock; 2007 Sep; 28(3):353-9. PubMed ID: 17545942
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-kappaB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis.
Matsuda N; Hattori Y; Jesmin S; Gando S
Mol Pharmacol; 2005 Apr; 67(4):1018-25. PubMed ID: 15576632
[TBL] [Abstract][Full Text] [Related]
11. Modulation of inhibitor kappaB kinase/ nuclear factor kappaB signaling during critical illness: a double-edged sword.
Groesdonk HV; Senftleben U
Crit Care Med; 2004 May; 32(5):1239; author reply 1239-40. PubMed ID: 15190989
[No Abstract] [Full Text] [Related]
12. NF-kappaB signaling pathway and its therapeutic implications in human diseases.
Sarkar FH; Li Y; Wang Z; Kong D
Int Rev Immunol; 2008; 27(5):293-319. PubMed ID: 18853341
[TBL] [Abstract][Full Text] [Related]
13. The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.
Buchholz TA; Garg AK; Chakravarti N; Aggarwal BB; Esteva FJ; Kuerer HM; Singletary SE; Hortobagyi GN; Pusztai L; Cristofanilli M; Sahin AA
Clin Cancer Res; 2005 Dec; 11(23):8398-402. PubMed ID: 16322301
[TBL] [Abstract][Full Text] [Related]
14. Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.
Montagut C; Tusquets I; Ferrer B; Corominas JM; Bellosillo B; Campas C; Suarez M; Fabregat X; Campo E; Gascon P; Serrano S; Fernandez PL; Rovira A; Albanell J
Endocr Relat Cancer; 2006 Jun; 13(2):607-16. PubMed ID: 16728586
[TBL] [Abstract][Full Text] [Related]
15. Protective roles of hydroxyethyl starch 130/0.4 in intestinal inflammatory response and survival in rats challenged with polymicrobial sepsis.
Feng X; Liu J; Yu M; Zhu S; Xu J
Clin Chim Acta; 2007 Feb; 376(1-2):60-7. PubMed ID: 16942763
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB as a molecular target in adjuvant therapy of gastrointestinal carcinomas.
Yu YY; Li Q; Zhu ZG
Eur J Surg Oncol; 2005 May; 31(4):386-92. PubMed ID: 15837045
[TBL] [Abstract][Full Text] [Related]
17. Effects of dimethyl sulfoxide, pyrrolidine dithiocarbamate, and methylprednisolone on nuclear factor-kappaB and heat shock protein 70 in a rat model of hemorrhagic shock.
Bini R; Olivero G; Trombetta A; Castagna E; Cotogni P
J Trauma; 2008 Apr; 64(4):1048-54. PubMed ID: 18404074
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic cholinesterase inhibition improves survival in experimental sepsis.
Hofer S; Eisenbach C; Lukic IK; Schneider L; Bode K; Brueckmann M; Mautner S; Wente MN; Encke J; Werner J; Dalpke AH; Stremmel W; Nawroth PP; Martin E; Krammer PH; Bierhaus A; Weigand MA
Crit Care Med; 2008 Feb; 36(2):404-8. PubMed ID: 18091537
[TBL] [Abstract][Full Text] [Related]
19. Pyrrolidine dithiocarbamate inhibits translocation of nuclear factor kappa-B in neurons and protects against brain ischaemia with a wide therapeutic time window.
Nurmi A; Vartiainen N; Pihlaja R; Goldsteins G; Yrjänheikki J; Koistinaho J
J Neurochem; 2004 Nov; 91(3):755-65. PubMed ID: 15485504
[TBL] [Abstract][Full Text] [Related]
20. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis.
Paterson RL; Galley HF; Webster NR
Crit Care Med; 2003 Nov; 31(11):2574-8. PubMed ID: 14605526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
